B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

RNASEH1

MOLECULAR TARGET

ribonuclease H1

UniProt: O60930NCBI Gene: 2462435 compounds

RNASEH1 (ribonuclease H1) is targeted by 5 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting RNASEH1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
17 deshydroxypyrogallin 4 carboxylic acid2.208
2myricetin-3-O-galactopyranoside [Supplementary Concept]0.691
3Quercetin0.691
4Hematoporphyrins Iron-free derivatives of heme with 4 methyl groups, 2 hydroxyethyl groups and 2 propionic acid groups attached to0.691
5juglone hydroxylase [Supplementary Concept] catalyzes0.691

About RNASEH1 as a Drug Target

RNASEH1 (ribonuclease H1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 5 compounds with documented RNASEH1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

RNASEH1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.